KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Change in Cash (2016 - 2025)

Eli Lilly's Change in Cash history spans 17 years, with the latest figure at -$2.5 billion for Q4 2025.

  • For Q4 2025, Change in Cash fell 2388.66% year-over-year to -$2.5 billion; the TTM value through Dec 2025 reached $4.0 billion, up 790.87%, while the annual FY2025 figure was $4.0 billion, 790.87% up from the prior year.
  • Change in Cash reached -$2.5 billion in Q4 2025 per LLY's latest filing, down from $6.4 billion in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $6.4 billion in Q3 2025 to a low of -$2.5 billion in Q4 2025.
  • Average Change in Cash over 5 years is $180.5 million, with a median of $12.4 million recorded in 2021.
  • Peak YoY movement for Change in Cash: plummeted 5603.64% in 2023, then soared 4312.65% in 2025.
  • A 5-year view of Change in Cash shows it stood at $30.3 million in 2021, then tumbled by 1916.5% to -$550.4 million in 2022, then surged by 179.61% to $438.2 million in 2023, then crashed by 123.14% to -$101.4 million in 2024, then tumbled by 2388.66% to -$2.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Change in Cash are -$2.5 billion (Q4 2025), $6.4 billion (Q3 2025), and $282.6 million (Q2 2025).